Merck Announces Formation of Merck Digital Ethics Advisory Panel
Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. Merck, a […]
Cancer
NASA Science, New Airlock Heads to Space Station on SpaceX Cargo Spacecraft
SpaceX launched its 21st commercial resupply mission to the International Space Station at 11:17 a.m. EST Dec. 6, 2020, from Launch Pad 39A at NASA’s […]
Merck and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
Merck and Artios today announced a global three year strategic research collaboration to discover and develop multiple precision oncology drugs. • Merck and Artios will […]
EU Commission Pharmaceutical Strategy for Europe -Affordable, accessible and safe medicines for all
The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, […]
A stronger EU health security framework
To create a more robust mandate for coordination by the Commission and EU agencies, the Commission is today proposing a new Regulation on serious cross-border […]
Stronger and more operational EU Medicine Agencies
The European Centre for Disease Control and Prevention and the European Medicines Agency have been at the forefront of the EU’s work to address COVID-19 […]
Building a European Health Union: Stronger crisis preparedness and response for Europe
Today, the European Commission is taking the first steps towards building the European Health Union announced by President von der Leyen in her State of […]
BioNTech to Present Data from BNT311 (GEN1046) and BNT131 (SAR441000) Programs at SITC 35th Annual Meeting
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that results from three clinical and preclinical studies have been accepted for presentation at the […]
Bayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™
Bayer has entered into an exclusive global license agreement with Systems Oncology, LLC, for ERSO™, a compound in pre-clinical development for the treatment of metastatic […]
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
• Roche will obtain co-development and co-commercialisation rights for pralsetinib, an investigational, precision therapy in late-stage development for people with RET-altered non-small cell lung cancer, […]
Roche’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints
Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary […]
Roche’s Tecentriq in combination with chemotherapy (including Abraxane) meets primary endpoint of improved pathological complete response
…. regardless of PD-L1 status, as initial treatment for people with early triple-negative breast cancer • IMpassion031 data will be discussed with health authorities globally, […]